| 000 | 01304 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250511222945.0 | ||
| 264 | 0 | _c19900517 | |
| 008 | 199005s 0 0 eng d | ||
| 022 | _a0039-2499 | ||
| 024 | 7 |
_a10.1161/01.str.21.4.596 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _adel Zoppo, G J | |
| 245 | 0 | 0 |
_aHemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction. _h[electronic resource] |
| 260 |
_bStroke _cApr 1990 |
||
| 300 |
_a596-601 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCerebral Hemorrhage _xchemically induced |
| 650 | 0 | 4 |
_aCerebral Infarction _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aImmunoradiometric Assay |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNervous System _xphysiopathology |
| 650 | 0 | 4 | _aPapio |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadverse effects |
| 700 | 1 | _aCopeland, B R | |
| 700 | 1 | _aAnderchek, K | |
| 700 | 1 | _aHacke, W | |
| 700 | 1 | _aKoziol, J A | |
| 773 | 0 |
_tStroke _gvol. 21 _gno. 4 _gp. 596-601 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.str.21.4.596 _zAvailable from publisher's website |
| 999 |
_c2115523 _d2115523 |
||